Area of research
Hematology · Molecular Biology
Research interest
Research interests include Autoimmune and Inflammatory Disorders Research, Inflammasome and immune disorders, Acute Lymphoblastic Leukemia research, and Immune Cell Function and Interaction.
Diagnostic guidelines for familial hemophagocytic lymphohistiocytosis revisited
Current treatment in macrophage activation syndrome worldwide: a systematic literature review to inform the METAPHOR project
Hyperferritinemia Screening to Aid Identification and Differentiation of Patients with Hyperinflammatory Disorders
The 2022 EULAR/ACR points to consider at the early stages of diagnosis and management of suspected haemophagocytic lymphohistiocytosis/macrophage activation syndrome (HLH/MAS)
The 2022 <scp>EULAR</scp>/<scp>ACR</scp> Points to Consider at the Early Stages of Diagnosis and Management of Suspected Haemophagocytic Lymphohistiocytosis/Macrophage Activation Syndrome (<scp>HLH</scp>/<scp>MAS</scp>)
Type I interferon signature and cycling lymphocytes in macrophage activation syndrome
Disease Course, Treatments, and Outcomes of Children With Systemic Juvenile Idiopathic Arthritis–Associated Lung Disease
Hyperferritinemic sepsis, macrophage activation syndrome, and mortality in a pediatric research network: a causal inference analysis
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 3
Machine learning derivation of four computable 24-h pediatric sepsis phenotypes to facilitate enrollment in early personalized anti-inflammatory clinical trials
Identification of Distinct Inflammatory Programs and Biomarkers in Systemic Juvenile Idiopathic Arthritis and Related Lung Disease by Serum Proteome Analysis
mTORC1 links pathology in experimental models of Still’s disease and macrophage activation syndrome
Mortality Risk in Pediatric Sepsis Based on C-reactive Protein and Ferritin Levels
First-line options for systemic juvenile idiopathic arthritis treatment: an observational study of Childhood Arthritis and Rheumatology Research Alliance Consensus Treatment Plans
Severe delayed hypersensitivity reactions to IL-1 and IL-6 inhibitors link to common HLA-DRB1*15 alleles
DDX17 is an essential mediator of sterile NLRC4 inflammasome activation by retrotransposon RNAs
Selected Abstracts from the 12th Annual Meeting of the Clinical Immunology Society: 2021 Virtual Annual Meeting: Immune Deficiency and Dysregulation North American Conference
On the Alert for Cytokine Storm: Immunopathology in <scp>COVID</scp>‐19
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 1
Pediatric hemophagocytic lymphohistiocytosis
American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS–CoV‐2 and Hyperinflammation in Pediatric COVID‐19: Version 2
Immunodeficiency and bone marrow failure with mosaic and germline TLR8 gain of function
Highways to hell: Mechanism-based management of cytokine storm syndromes
Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases
Emergent high fatality lung disease in systemic juvenile arthritis
An emergent, high-fatality lung disease in systemic juvenile arthritis
P127 Lung disease in systemic JIA: an emerging problem linked with young age and anti-IL-1/IL-6
Interleukin-18 diagnostically distinguishes and pathogenically promotes human and murine macrophage activation syndrome
NLRC4 inflammasomopathies
An activating NLRC4 inflammasome mutation causes autoinflammation with recurrent macrophage activation syndrome